Non-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia.
CONCLUSIONS: There are currently no convincing data to support a benefit for NSAIDs in the treatment of CIN. With the addition of this new, larger randomised trial we would rate this as overall moderate-certainty evidence by the GRADE criteria.
PMID: 29431861 [PubMed - as supplied by publisher]
Source: Cochrane Database of Systematic Reviews - Category: General Medicine Authors: Grabosch SM, Shariff OM, Helm CW Tags: Cochrane Database Syst Rev Source Type: research
More News: Bleeding | Cancer | Cancer & Oncology | Carcinoma | Celebrex | Cervical Cancer | Databases & Libraries | Gastroenterology | General Medicine | OBGYN | Oral Cancer | Pain | Pregnancy | Premature Birth | Study | Toxicology | Vioxx | Women